⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1374665 | 1.00 | — | — | |
| SCHEMBL286696 | 0.85 | TSHR (0.48) | — | |
| SCHEMBL3884 | 0.85 | TSHR (0.48) | — | |
| SCHEMBL9421049 | 0.83 | TSHR (0.52) | — | |
| SCHEMBL62945 | 0.83 | TSHR (0.52) | — | |
| SCHEMBL2285719 | 0.81 | CES1 (0.41) | — | |
| SCHEMBL177122 | 0.81 | TSHR (0.50) | — | |
| SCHEMBL20477815 | 0.77 | TSHR (0.38) | — | |
| SCHEMBL456207 | 0.75 | TSHR (0.36) | — | |
| SCHEMBL1191865 | 0.75 | TSHR (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10571 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024150815-A1 | CEREBLON E3 LIGASE BINDING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PRODUCTION METHOD THEREFOR | 田辺三菱製薬株式会社 | 2024-07-18 | — | — | WO | claimed |
| US-20240239766-A1 | 3-AMINO PIPERIDYL SODIUM CHANNEL INHIBITORS | GENENTECH, INC. (US) | 2024-07-18 | — | — | US | claimed |
| CN-118354995-A | Novel compound and organic light emitting device comprising the same | 株式会社LG化学 | 2024-07-16 | — | — | CN | claimed |
| CN-118339142-A | Novel compound and organic light emitting device using the same | 株式会社LG化学 | 2024-07-12 | — | — | CN | claimed |
| EP-4397661-A1 | COMPOUND FOR DEGRADATION OF BCL-2 FAMILY PROTEINS AND MEDICAL APPLICATION THEREOF | Xizang Haisco Pharmaceutical Co., Ltd. (CN) | 2024-07-10 | — | — | EP | claimed |
| EP-4396187-A1 | NAPHTHYRIDINE COMPOUNDS AS INHIBITORS OF KRAS | Incyte Corporation (US) | 2024-07-10 | — | — | EP | claimed |
| EP-4397664-A1 | PYRIMIDINE-FUSED CYCLIC COMPOUND AND PREPARATION METHOD AND USE THEREOF | Genfleet Therapeutics (Shanghai) Inc. (CN) | 2024-07-10 | — | — | EP | claimed |
| CN-118290446-A | Compound for inhibiting and degrading c-MYC and medical application thereof | 西藏海思科制药有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-118271316-A | Cycloheptenyl-containing derivative, pharmaceutical composition and pharmaceutical application thereof | 西藏海思科制药有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-118255780-A | Compound for inhibiting and degrading c-MYC and medical application thereof | 西藏海思科制药有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-88103408-A | Process for preparing (1H-oxazol-1-ylmethyl) substituted benzotriazole derivatives | — | 1988-12-14 | — | — | CN | claimed |
| US-4767749-A | CARDIOTONIC AGENTS | AMERICAN CYANAMID COMPANY (US) | 1988-08-30 | — | — | US | claimed |
| CN-85108556-A | The preparation method of novel benzoxazol base and benzothiazolyl amino derivative and application thereof | — | 1986-07-30 | — | — | CN | claimed |
| EP-0184257-A1 | Benzoxazol- and benzothiazolamine derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 1986-06-11 | — | — | EP | claimed |
| EP-0076530-B1 | NOVEL N-(3-HYDROXY-4-PIPERIDINYL)BENZAMIDE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 1985-12-11 | — | — | EP | claimed |
| EP-0121972-A2 | N-aryl-alpha-amino-carboxamides | JANSSEN PHARMACEUTICA N.V. (BE) | 1984-10-17 | — | — | EP | claimed |
| EP-0076530-A2 | Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 1983-04-13 | — | — | EP | claimed |
| US-4255506-A | A PHOTOSENSITIVE ORGANIC PIGMENT CONTAINING ONE OR MORE VINYL GROUPS AND RING(S) OF BENZENE, NAPHTHALENE, ANTHRACENE, AND/OR DIBENZOTHIENE; COPIERS | EASTMAN KODAK COMPANY (US) | 1981-03-10 | — | — | US | claimed |
| US-4181802-A | ADRENERGIC BLOCKING AGENTS | JANSSEN PHARMACEUTICA N.V. (BE) | 1980-01-01 | — | — | US | claimed |
| EP-0005610-A2 | 1-(Heterocyclylalkyl)-1,3-dihydro-2H-benzimidazol-2-ones, their preparation, their pharmaceutical compositions and their use as beta-adrenergic receptor blockers | JANSSEN PHARMACEUTICA N.V. (BE) | 1979-11-28 | — | — | EP | claimed |